In "Made in China 2025", the top ten industries such as biomedicine and high-performance medical devices have been promoted to "national strategy" and have received widespread attention. However, with the continuous advancement of medical reform, China's imported medical devices have shown a continuous growth trend, which once again triggered industry concerns about the monopoly of the domestic medical device market.
High-end products are all "made in foreign countries"
The data shows that in recent years, China's imported medical devices have continued to grow. In 2012 and 2013, the value of China's medical device imports was 124.72 and 14.975 billion US dollars, up 14.56% and 20.07% respectively. In 2014, the value of imports was 15.771 billion US dollars, an increase of 5.32%. The relevant person in charge of the Jinan Entry-Exit Inspection and Quarantine Bureau told the reporter that with the continuous advancement of medical reforms this year, the demand for imported medical devices by medical institutions is still increasing. From January to July 2015, the value of imported medical devices in Jinan alone was 4148.43. Ten thousand dollars, an increase of 39.66%.
Compared with the continuous growth of imported medical devices, the monopoly of foreign brands on the domestic medical market is even more worrying to the industry. Prospective Industry Research Institute's "2014-2018 China Medical Device Industry Market Preview and Investment Forecast Analysis Report" pointed out that in China's medical device field, about 80% of the CT market, 90% of the ultrasonic instrument market, and 85% of the test instrument market 90% of magnetic resonance equipment, 90% of ECG market, 80% of high-end monitor market, and 90% of high-end physiological recorder market are monopolized by foreign companies. In some areas, the coverage of imported equipment can reach 100%.
The reporter learned that in recent years, the informationization and networking trends in the medical field have led to an increase in demand for sophisticated medical devices such as intelligence, imaging, and digitization, and there is still a large gap between domestic products and developed countries in the field of high-end medical equipment. .
"The market share of domestic brands and foreign brands in the medical device market is 37, which is recognized by the industry." A person in charge of a foreign trade agency specializing in the import and export of medical equipment told reporters. "From the current situation, 90% of domestic and high-end imaging equipment in domestic hospitals are made in foreign countries. From the perspective of the whole province, large-scale high-end video equipment is almost entirely made in foreign countries." 2 Market monopoly "raise" medical costs
According to industry insiders, a few foreign brands monopolize the mid-to-high-end medical device market, causing all kinds of chaos, leading to rising medical costs, which has aggravated the problem of “expensive medical treatmentâ€.
Wei Yujie, deputy chief of the Department of Mechatronics, Inspection and Inspection Bureau of Jinan Entry-Exit Inspection and Quarantine Bureau, said that because a small number of foreign brands control high-end medical device products, the price of such products has been artificially high for a long time. "General-purpose, Philips, Siemens medical equipment in China is generally 50% to 100% higher than the country of origin such as Europe, the United States, Japan. For example, Tomo radiotherapy equipment in Europe, America and other countries is more than 2.5 million US dollars, in China It is more than $5 million; similarly, spiral CT products are priced at $1.5 million in the international market, while domestic market quotes are often between $2 million and $2.5 million."
It is understood that imported medical device dealers usually adopt the marketing model of “free gift equipment and bundled consumables†for inspection equipment to seize the Chinese market and make profits with consumables. Although this model allows hospitals to obtain advanced medical equipment for free, it has passed on the high cost of consumables to patients and medical insurance funds, which has had a huge impact on the domestic high-end medical equipment industry. "With the hemodialysis machine as an example, the price of bundled consumables is at least 100 yuan higher than the average consumables, so that foreign brands can charge at least 120,000 yuan per year from a hemodialysis machine, and import one hemodialysis machine. The price is only 12 to 150,000 yuan."
It is worth noting that the large equipments of major hospitals, such as CT machines and nuclear magnetic resonance instruments, can basically rely on the purchase of warranty contracts to ensure the operation of the equipment. The annual warranty price is 6% of the contract costs from a dozen years ago. Soaring to the current nearly 15%. The after-sales market has long been in a state of monopoly by foreign-funded enterprises, resulting in high prices for maintenance and consumables, and has become the main source of profits for foreign-funded enterprises operating medical devices in China.
China Medical Intermediate,Powder Capsule supplier & manufacturer, offer low price, high quality Artemisinin Powder Supplement,Alpha Gpc Powder, etc.
We had passed FDA certificate and ISO 9001 .
Welcome any inquiry and question on our featured products
Medical Intermediate,Powder Capsule,Artemisinin Powder Supplement,Alpha Gpc Powder
Xi'an Healthway Biotech Co.,Ltd , http://www.xahealthway.com